Skip to content

Embecta Corp. EMBC Market capitalization

Market capitalization at other companies

Insulet logo
InsuletPODD
$14.77B-19.9%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$1.31B+2.8%
Medtronic logo
MedtronicMDT
$103.96B-3.8%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$188.3M-27.3%
Mannkind logo
MannkindMNKD
$754.85M-50.6%
Beta Bionics, Inc. Common Stock logo
Beta Bionics, Inc. Common StockBBNX
$444.71M

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Computed from the period-end share price: $523.5M.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s market capitalization?
Embecta Corp. (EMBC) reported market capitalization of $523.5M in Q1 2026.
How has Embecta Corp.'s market capitalization changed year-over-year?
Embecta Corp.'s market capitalization decreased by 29.4% year-over-year, from $741.21M to $523.5M.
What is the long-term trend for Embecta Corp.'s market capitalization?
Over 3 years (2022 to 2025), Embecta Corp.'s market capitalization has grown at a -20.6% compound annual growth rate (CAGR), from $1.65B to $825.23M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.